Key Study Metrics
Total Enrollments
Our partcipation level has exceeded our expectations. Please contact us for information on how to participate
0
Active Participants
0
Completed Study
0
Study Enrollment
Currently, 2,315 of the 10,742 participants in the aspirin study have been filled.
Percentage
23.6%
Study Enrollment Per Site
Site specific information
Ohio State University
0
University of Texas Houston
0
University of Pittsburgh
0
Old Dominion University
0
University of San Francisco
0
Cedars Sinai
0
Columbia
0
University of North Carolina
0
Northwestern
0
New Mexico
0
Brown
0
Inova
0
Mississippi
0
University of Utah
0
Medical College of Wisconsin
0
University of Alabama
0
Participant Testimonials
“I wish I had known the ins and outs of how I could have prevented preeclampsia, or managed it better,” she shares. “Now, I’m very passionate about trying to help other new moms who could experience preeclampsia.”
Lysette Franco
Community Advisory Board
“After (centuries) without a significant treatment (for preeclampsia), this is currently the most viable option. We must focus on learning as much about it as we can.”
Elena Tsigas
Community Advisory Board
"By involving patients, caregivers and other partners in research, we aim to deliver findings that empower families to make confident decisions with their (clinicians) and ultimately improve outcomes for parents and children,”
Maged Costantine, M.D.
Study Principal Investigator